Report: US VC funding hit $84B in 2017, most since the dotcom boom, across 8,076 deals, fewest since 2012; unicorns accounted for 23% of funding, 0.9% of deals
Venture capitalists were busy in 2017, pouring $84 billion into 8,035 companies across the U.S..
Context & Ripple Effects
This report lands one year after VCs pulled back to $69B across 7,350 companies in 2016, itself a retreat from the 2015 peak — so the headline number reads as a rebound, not a surprise. What matters is the shape underneath it: the same mega-deal concentration TechCrunch flagged when global Q2 2016 funding rose on fewer deals has now reached the US annual totals.
Unicorns taking 23% of all US funding on just 0.9% of deals means the 2017 record was carried by a tiny cohort of late-stage names while the check count fell to its lowest since 2012. That barbell — record dollars, shrinking breadth — is the data point the following years keep confirming.
First-order effects
- Founders outside the unicorn tier face a thinner market: 8,076 deals is the fewest since 2012, so early- and mid-stage companies are competing for a shrinking share of a growing pool.
- Late-stage investors and their LPs are concentrating exposure — nearly a quarter of deployed capital now rides on under 1% of portfolio companies.
Second-order effects
- Seed and Series A funds are pushed toward specialization or earlier entry to avoid bidding against mega-rounds for proven names, while growth-stage valuations inflate as capital chases the same small set of scale-ups.
- The unicorn cohort's grip tightens downstream: by the time CB Insights counted 959 unicorns globally in 2021, up 69%, the 2017 pattern had become the industry's default pipeline.
Third-order effects
- If the pattern holds — and it did through 2018's $99.5B on the fewest deals since 2013 and 2020's record $130B with deal counts falling for a second straight year — US venture structurally bifurcates into a concentrated winner-take-most layer and a starved long tail, changing which startups get funded at all.
- A decade of this dynamic points toward venture returns consolidating around a handful of scaled companies per cycle, raising the stakes for regulators and LPs assessing concentration risk in what is nominally a diversified asset class.
The trend: US venture capital is consolidating into ever-fewer, larger checks — record dollar totals paired with shrinking deal counts year after year.